
Arenobufagin | CAS:464-74-4
Arenobufagin
- Name:Arenobufagin
- CAS:464-74-4
- Synonyms:(3beta,5beta,11alpha)-3,11,14-Trihydroxy-12-oxobufa-20,22-dienolide
- Molecular Formula:C24H32O6
- Molecular Weight:416.51
- EINESC:
Description
Properties
Melting point | 222-228 ºC |
---|---|
Density | 1.349 |
Safety
没有数据 | 没有数据 |
---|
SDS
Source | SDS/MSDS Samples |
---|---|
没有数据 | 没有数据 |
Synthetic Route
Name | CAS |
---|
More
Articles
Peer-Reviewed Papers
Gomisin A enhances tumor necrosis factor-α-induced G1 cell cycle arrest via signal transducer and activator of transcription 1-mediated phosphorylation of retinoblastoma protein.Pornthip Waiwut et al.Biological & pharmaceutical bulletin, 35(11), 1997-2003 (2012-11-06)
Gomisin A inhibits lipopolysaccharide-induced inflammatory responses in N9 microglia via blocking the NF-κB/MAPKs pathway.Xiaoxiao Wang et al.Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 63, 119-127 (2013-11-12)
Protective effects of gomisin A isolated from Schisandra chinensis against CCl4-induced hepatic and renal injuryHwang I S, et al. International Journal of Molecular Medicine, 31(4), 888-898 (2013)
Gomisin A modulates aging progress via mitochondrial biogenesis in human diploid fibroblast cells.Jeong-Seok Kim et al.Clinical and experimental pharmacology & physiology, 45(6), 547-555 (2018-01-11)
Schisandra chinensis extract ameliorates age-related muscle wasting and bone loss in ovariectomized rats.Jeong-Seok Kim et al.Phytotherapy research : PTR, 33(7), 1865-1877 (2019-05-11)
Antihypertensive effect of gomisin A from Schisandra chinensis on angiotensin II-induced hypertension via preservation of nitric oxide bioavailability.Ji Young Park et al.Hypertension research : official journal of the Japanese Society of Hypertension, 35(9), 928-934 (2012-04-27)
Remarks
Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).
Name | CAS |
---|

Related Products
Related News
Question
Hot Tags
Inquiry
Fill in related informations ;please!
- Please fill in product name !
- CAS
- Please fill in your company information correctly!
- Please fill in liaison information correctly!
- Please fill in your telephone number correctly!
- Please fill in your email correctly!
- Please describe the problem of products!